Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Narcisi, P.
Right arrow Articles by Pope, F.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narcisi, P.
Right arrow Articles by Pope, F.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 Oxford University Press

OTHER

A family with Ehlers — Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen

Paolo Narcisi, Allan J.Richards*, Stanley D. Ferguson1 and F.Michael Pope

Dermatology Research Group, Clinical Research Centre Watford Road, Harrow, Middlesex HA1 3UJ 1Department of Paediatrics, Royal Gwent Hospital Newport, Gwent, UK

*To whom correspondence should be addressed

Received May 10, 1994; Revised July 6, 1994; Accepted July 6, 1994

Ehlers — Danlos syndrome (EDS) is a heterogeneous group of heritable disorders of connective tissue. The type III variety is characterized by joint hypermobility and minor hyperextensibility and softness of the skin. While collagen fibril structure has been shown to be abnormal in such patients, the underlying molecular defect(s) has not been determined. Here we characterize the first mutation found in a family with EDS III. Analysis of cultured fibroblasts from the affected family revealed intracellular retention of type III collagen. This is usually a biochemical characteristic of EDS IV, caused by mutations of COL3A1. Analysis of the cDNA sequence in this EDS III family revealed a glycine to serine mutation at amino acid residue 637 of the type III collagen molecule. This was confirmed by allele-specific oligonucleotide hybridization against amplified genomic DNA. Thus mutations of type III collagen can cause either EDS IV or EDS III. Two affected family members had virtually normal skin and so more closely resembled the phenotype of articular hypermobility syndrome.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
F. Malfait, A. J. Hakim, A. De Paepe, and R. Grahame
The genetic basis of the joint hypermobility syndromes
Rheumatology, May 1, 2006; 45(5): 502 - 507.
[Full Text] [PDF]

Home page
 NeurologyHome page
T. Brandt, E. Orberk, R. Weber, I. Werner, O. Busse, B. T. Muller, F. Wigger, A. Grau, C. Grond-Ginsbach, and I. Hausser
Pathogenesis of cervical artery dissections: Association with connective tissue abnormalities
Neurology, July 10, 2001; 57(1): 24 - 30.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Pepin, U. Schwarze, A. Superti-Furga, and P. H. Byers
Clinical and Genetic Features of Ehlers-Danlos Syndrome Type IV, the Vascular Type
N. Engl. J. Med., March 9, 2000; 342(10): 673 - 680.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.